Lewis Joel has bought 820,299 shares of
Galectin Therapeutics Inc [GALT] at $2.07 a share.
Galectin Therapeutics Inc [GALT] disclosed in an SEC Form 4 submission Tuesday, February 28, 2023 that the deal increased Lewis Joel's holding in the company to 75,529.
Galectin Therapeutics Inc [GALT] is a Pharmaceutical Preparations company based in Nevada.Also Read:Galectin Therapeutics contribution to improve histology interpretation of cirrhotic liver ...Galectin Therapeutics to Present at 6th Obesity & NASH Drug Development Summit
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
![LEWIS JOEL buys 820,299 shares of GALECTIN THERAPEUTICS INC [GALT]](/_next/image?url=https%3A%2F%2F10k-staging.s3.us-west-2.amazonaws.com%2Fnews_images%2Farticle_GALT_i3_20235102120378784.jpg&w=1200&q=75)